OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ONEG60

One Glove Group Bhd

Medical Equipment, Supplies & DistributionVerified

One Glove Group Bhd exhibits a capital structure with a debt-to-equity ratio of 1.05, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.23, suggesting limited short-term liquidity cushion. Free cash flow is negative at -26.2 million MYR, and operating cash flow is also negative at -14.6 million MYR, reflecting ongoing cash outflows from operations. Profitability metrics are negative, with a return on equity of -25.78% and a return on assets of -7.97%. These figures are significantly below the industry norms for medical equipment and supplies firms, which typically exhibit positive returns. The company's operating income and net income are both negative, at -26.45 million MYR and -31.63 million MYR, respectively, indicating a loss-making position. The company's revenue is concentrated in the Glove Manufacturing segment, which is the primary source of its operations. However, the financial snapshot does not provide specific revenue breakdowns by segment or geography. Given the company's operations in Malaysia, it is likely that a significant portion of its revenue is derived from the domestic market, though this is not explicitly stated in the available data. The company's growth trajectory is currently negative, with a net income decline and a negative operating cash flow. The outlook for the current fiscal year does not indicate a reversal of this trend, and there is no provided data for the next fiscal year. The company's revenue in the latest period was 35.47 million MYR, which is lower than the analyst-estimated revenue of 65.26 million MYR, suggesting a significant underperformance. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The risk assessment also notes a low dilution risk, but the company's negative free cash flow and operating cash flow suggest potential pressure on liquidity. No dilution sources are explicitly cited in the input data, and no adjustments are applied in the custom valuations. Recent events include a reported negative earnings per share of -0.01 MYR and a negative ESG controversies score of 100.0, indicating significant ESG-related issues. The governance and social pillars of the ESG score are 65.7 and 57.7, respectively, suggesting moderate governance performance and below-average social performance.

30-day price · ONEG+0.01 (+7.7%)
Low$0.12High$0.14Close$0.14As of24 May, 00:00 UTC
Profile
CompanyOne Glove Group Bhd
TickerONEG.KL
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. One Glove Group Bhd is a Malaysia-based investment holding company that primarily engages in the manufacturing, marketing, and selling of non-sterile, powder-free, nitrile examination gloves, including products such as Ultraviolet, Violet Blue, Cobalt Blue, Sky Blue, and Black.

Classification. One Glove Group Bhd is classified under the industry "Medical Equipment, Supplies & Distribution" within the "Healthcare Services & Equipment" business sector, with a classification confidence of 0.92.

One Glove Group Bhd exhibits a capital structure with a debt-to-equity ratio of 1.05, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.23, suggesting limited short-term liquidity cushion. Free cash flow is negative at -26.2 million MYR, and operating cash flow is also negative at -14.6 million MYR, reflecting ongoing cash outflows from operations. Profitability metrics are negative, with a return on equity of -25.78% and a return on assets of -7.97%. These figures are significantly below the industry norms for medical equipment and supplies firms, which typically exhibit positive returns. The company's operating income and net income are both negative, at -26.45 million MYR and -31.63 million MYR, respectively, indicating a loss-making position. The company's revenue is concentrated in the Glove Manufacturing segment, which is the primary source of its operations. However, the financial snapshot does not provide specific revenue breakdowns by segment or geography. Given the company's operations in Malaysia, it is likely that a significant portion of its revenue is derived from the domestic market, though this is not explicitly stated in the available data. The company's growth trajectory is currently negative, with a net income decline and a negative operating cash flow. The outlook for the current fiscal year does not indicate a reversal of this trend, and there is no provided data for the next fiscal year. The company's revenue in the latest period was 35.47 million MYR, which is lower than the analyst-estimated revenue of 65.26 million MYR, suggesting a significant underperformance. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. The risk assessment also notes a low dilution risk, but the company's negative free cash flow and operating cash flow suggest potential pressure on liquidity. No dilution sources are explicitly cited in the input data, and no adjustments are applied in the custom valuations. Recent events include a reported negative earnings per share of -0.01 MYR and a negative ESG controversies score of 100.0, indicating significant ESG-related issues. The governance and social pillars of the ESG score are 65.7 and 57.7, respectively, suggesting moderate governance performance and below-average social performance.
Key takeaways
  • One Glove Group Bhd is currently operating at a loss, with negative net income and operating income.
  • The company's liquidity position is weak, with a current ratio of 1.23 and negative free cash flow.
  • The company's profitability metrics are significantly below industry norms, with a return on equity of -25.78%.
  • The company's ESG controversies score is 100.0, indicating significant ESG-related issues.
  • The company's revenue is below analyst estimates, suggesting a significant underperformance.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$35.5M
Gross profit-$12.9M
Operating income-$26.5M
Net income-$31.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$14.6M
CapEx-$4.6M
Free cash flow-$26.2M
Total assets$396.7M
Total liabilities$274.0M
Total equity$122.7M
Cash & equivalents
Long-term debt$128.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$122.7M
Net cash-$128.6M
Current ratio1.2
Debt/Equity1.1
ROA-8.0%
ROE-25.8%
Cash conversion46.0%
CapEx/Revenue-12.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricONEGActivity
Op margin-74.6%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-89.2%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin-36.5%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-12.9%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity105.0%69.3% medp25 63.4% · p75 74.5%top quartile
Observations
IR observations
Last actual EPS-0.01 MYR
Last actual revenue65,257,000 MYR
market data ESG controversies score100.0
market data ESG governance pillar65.7
market data ESG social pillar57.7
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 07:34 UTC#ce4bbd83
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 07:35 UTCJob: 8a28dff2